Published • loading... • Updated
NeoGenomics, Inc. (NEO) Stock Analysis: Unveiling A 27.68% Potential Upside In The Diagnostics Sector
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
NeoGenomics, Inc. (NEO) Stock Analysis: Unveiling A 27.68% Potential Upside In The Diagnostics Sector
NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, stands out in the diagnostics and research industry. With a market capitalization of $1.71 billion, this Fort Myers, Florida-based company operates a network of cancer-focused testing laboratories across the United States and the United Kingdom. Catering to hospitals, academic centers, pathologists, and pharmaceutical companies, NeoGenomics provides a comprehensive sui…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
